RecruitingPhase 4NCT05418556

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug

Sponsor

Asan Medical Center

Enrollment

3,944 participants

Start Date

Oct 21, 2022

Study Type

INTERVENTIONAL

Conditions

Coronary Artery Disease

Summary

Objectives: To assess the safety of tailored antiplatelet therapy (short DAPT followed by P2Y12 inhibitor alone strategy) in patients who received optimized DES implantation guided by intravascular imaging (IVUS or OCT) Hypothesis: Tailored antiplatelet strategy (short DAPT followed by P2Y12 inhibitor alone) is superior to conventional antiplatelet strategy in terms of clinically relevant bleeding and noninferior for ischemic composite adverse events in patients who received intravascular imaging-guided optimized DES implantation. (Optimized stent evaluated by on-site IVUS/OCT could act as an essential criterion for decision making for tailored antithrombotic strategy)

Eligibility

Min Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called aspirin for people with coronary artery disease. The study is currently recruiting participants at 33 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGaspirin

DAPT strategy

Locations(33)

Bucheon Sejong Hospital

Bucheon-si, South Korea

Dong-A University Hospital

Busan, South Korea

Inje University Busan Paik Hospital

Busan, South Korea

Inje University Haeundae Paik Hospital

Busan, South Korea

Kosin University Gospel Hospital

Busan, South Korea

Gyeongsang National University Changwon Hospital

Changwon, South Korea

Kangwon National University Hospital

Chuncheon, South Korea

Chungbuk National University Hospital

Chungju, South Korea

Daegu Catholic Univ Medical Center

Daegu, South Korea

Keimyung University Dongsan Medical Center

Daegu, South Korea

Kyungpook National University Hospital

Daegu, South Korea

Veterans Hospital

Daegu, South Korea

The Catholic University of Korea, Daejeon ST. Mary's Hospital

Daejeon, South Korea

Gangneung Asan Hospital

Gangneung, South Korea

Hallym Univ. Medical Center.

Hwaseong-si, South Korea

dongguk University Medical Center

Ilsan, South Korea

Jeju National University Hospital

Jeju City, South Korea

Jeonbuk National University Hospital

Jeonju, South Korea

Gyeongsang National University Hospital

Jinju, South Korea

Chungnam National University Hospital

Jungnam, South Korea

Chungnam National University Sejong Hospital

Jungnam, South Korea

Dankook University Hospital

Jungnam, South Korea

Asan Medical Center

Seoul, South Korea

Kangbuk Samsung Hospital

Seoul, South Korea

Korea University Anam Hospital

Seoul, South Korea

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Seoul, South Korea

Veterans Hospital Service Medical Center

Seoul, South Korea

Ajou University Hospital

Suwon, South Korea

The Catholic University of Korea, ST. Vincent's Hospital

Suwon, South Korea

The Catholic University of Korea, Uijeongbu ST. Mary's Hospital

Uijeongbu-si, South Korea

Dongkang Hospital

Ulsan, South Korea

Ulsan University Hospital

Ulsan, South Korea

Pusan National University Yangsan Hospital

Yangsan, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05418556

Related Trials

Digital Long-term Follow-up of Patients With Coronary Artery Disease

NCT077203492 locations

Gangwon PCI Prospective Registry

NCT020381273 locations

Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions

NCT0719069018 locations

Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

NCT072582902 locations

Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

NCT0677963023 locations